Explore how germline testing identifies inherited cancer risk, guides earlier screening and prevention, and provides valuable insights for patients and their families.
Anil Bajnath, MD, MBA, IFMCP, ABAARMExplore eight advances in precision medicine, from rapid genomic sequencing and targeted cancer therapies to gene therapy, and discover what these breakthroughs mean for clinical practice.
Explore how digital biomarkers and wearable technologies are enabling continuous health monitoring, early disease detection, and more personalized approaches to precision medicine.
Explore how clinicians interpret molecular diagnostic reports and translate genomic, transcriptomic, and proteomic findings into informed, personalized treatment decisions.
Discover how molecular biomarkers such as HER2, KRAS, and PD-L1 are helping guide treatment selection, clinical trials, and personalized cancer care.
Anil Bajnath, MD, MBA, IFMCP, ABAARMEmerging research is uncovering connections between multiple sclerosis, the gut microbiome, genetics, and immune function. Explore what these findings could mean for the future of precision medicine.
A multidisciplinary community committed to advancing research, education, and clinical standards in precision medicine.
Copyright 2026. American Board of Precision Medicine. All Rights Reserved.
